Clinical Trial Update: Fludarabine, Cyclophosphamide, and Alemtuzumab in Patients With B-cell Chronic Lymphatic Leukemia (B-CLL) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of fludarabine, cyclophosphamide, and alemtuzumab in patients with chronic lymphocytic leukemia has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Alemtuzumab (Campath) (alemtuzumab)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine (Fludarabine)

Snippet

Sponsor: German CLL Study Group | Conditions: B-cell Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED